The Long, Strange History of Grave Robbing and Its Modern Counterpart

An article by Addicen Bauer
Read More

HTN 2024 Healthcare Predictions: Looking Back to Move Forward

Setting the pace
Read More

Without PBM Reform and an IRA Fix, Drug Shortages Are Inevitable

An article by Ted Love, RealClear Health
Read More

How Black and Hispanic Americans view clinical trials

An article by Alison Spencer and Cary Funk
Read More

Clinical trial redesign must be defined by diversity

PharmaTimes Magazine. April, 2023 edition
Read More

Henrietta Lacks' descendants reach a settlement over the use of her 'stolen' cells

Settlement reached
Read More

Family of Henrietta Lacks reaches settlement in lawsuit over her cells

This New Drug May Be Our Best Chance in Fighting Alzheimer’s

FDA approves new drug
Read More

Black communities endured wave of excess deaths in past 2 decades, studies find

The Washington Post reveals that the loss of life came at a staggering cost, medically and economically
Read More

Study: Black Americans Live Longer When There Are More Black Doctors In The Country

Time and again, it has been stressed that representation matters. Studies have shown it matters in education. It matters in the judicial system. And a new study shows it matters in the medical field.
Read More

Optimizing Patient Recruitment and Engagement Strategies

Engaging the NBCI Model to Ensure Minority Participation
Read More

Two cancer drug trials put on hold after patients died, companies say

Two clinical trials have been paused within the past two days because six participants – including one child – have died, according to reports by the drug companies.
Read More

Viewpoint: The Politics of Informed Consent and the Limits of the First Amendment

Physicians are accustomed to disclosing the risks and benefits of treatment as part of their ethical and legal duty to secure informed consent.
Read More

Study: Black Americans Live Longer When There Are More Black Doctors In The County

Time and again, it has been stressed that representation matters. Studies have shown it matters in education. It matters in the judicial system. And a new study shows it matters in the medical field.
Read More

Treatment of Rare Anemias Shifting Rapidly

A wave of new therapies is starting to reshape the treatment landscape for people with rare anemias, but the authors of a new review also caution that more research is needed to better understand which therapies are right for which patients.
Read More

SCDAA, 8 pharma companies team up to increase trial participation

The Sickle Cell Disease Association of America (SCDAA) is collaborating with several pharmaceutical companies in a new initiative aimed at increasing awareness of the blood disorder and promoting clinical trial participation.
Read More

NMA Forms Project IMPACT 2.0 Coalition to Increase Minority Participation in Clinical Trials

The National Medical Association (NMA) is launching the formation of the Project IMPACT 2.0 (Increase Minority Participation and Awareness of Clinical Trials) Coalition.
Read More